Ingrilimine, a novel marine cytotoxic and apoptotic cyclic imine toxin with a high affinity and dual activity on human α7 nicotinic acetylcholine receptor
Abstract
Cyclic imine toxins are fast acting neurotoxins produced by dinoflagellates that are bioaccumulated by shellfish, which in turn, vectorize them to humans. Most cyclic imine toxins are potent antagonist of muscle and neuronal nicotinic acetylcholine receptors being able to cross the brain blood barrier. We report the discovery of ingrilimine, a novel cyclic imine toxin purified from Vulcanodinium rugosum (strain IFR-VRU-01). Its structure was determined by NMR, HRMS MS/MS and IR-spectroscopy. Ingrilimine bears a six-membered spirocyclic imine imbibed in a 13-carbon macrocycle (C24H35O2N; Mr 369.2663) and it is the smallest cyclic imine toxin described to date. Ingrilimine belongs to a novel emergent class of cyclic imines exhibiting potent cytotoxic and pro-apoptotic activities against human cancer cell lines. It also shows a high affinity for the human α7 nicotinic acetylcholine receptor displaying an intriguing dual activity: a concentration-dependent antagonist/agonist activity. Boltz-modeling of ingrilimine binding to human α7 nicotinic acetylcholine receptor rationalizes ingrilimine antagonist behavior, predicting at the same time the interaction of ingrilimine with the transmembrane domain of the receptor. Voltage clamp experiments using L247T and M253L receptor mutants indicate that Met253 located in transmembrane domain-2 may be essential for the ingrilimine-induced activation of α7 nicotinic acetylcholine receptor channel. Singular molecules like ingrilimine represent novel plausible routes for the treatment of neurodegenerative disorders and cancer where α7 nicotinic acetylcholine receptor plays a pivotal role. Harmful algal blooms are neglected sources of bioactive compounds with original scaffolds that can be used as drug leads for the treatment of human diseases.
Related
- Activation of α7 Nicotinic Acetylcholine Receptor Inhibits Neutrophil ex vivo Swarming and Pulmonary Recruitment in Inflamed Mice through an Integrin αMβ2-dependent Mechanism
- Mass photometry and its expanding role in membrane protein research: The Torpedo marmorata nicotinic acetylcholine receptor as case study
- Alpha-7 nicotinic acetylcholine receptor activation preserves podocyte integrity during sepsis-associated kidney injury
- Three-dimensional object-based quantification of nicotinic acetylcholine receptor subunit colocalization using Imaris
- Nicotinic control of dopamine release shapes striatal output and engages adaptive action selection.
BibTeX
@article{delepierre2026ingrilimine,
title = {{Ingrilimine, a novel marine cytotoxic and apoptotic cyclic imine toxin with a high affinity and dual activity on human α7 nicotinic acetylcholine receptor}},
author = {Muriel Delepierre and Claire Lamoise and Alice M.S. Rodrigues and Amandine Gaudin and Jérôme Bignon and Ludovic Jean and Arnaud Blondel and J. Iñaki Guijarro and Denis Servent and Rómulo Aráoz},
journal = {Chemosphere},
year = {2026},
month = may,
doi = {10.1016/j.chemosphere.2026.144955},
url = {https://cnrs.hal.science/hal-05798527v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Ingrilimine, a novel marine cytotoxic and apoptotic cyclic imine toxin with a high affinity and dual activity on human α7 nicotinic acetylcholine receptor
AU - Muriel Delepierre
AU - Claire Lamoise
AU - Alice M.S. Rodrigues
AU - Amandine Gaudin
AU - Jérôme Bignon
AU - Ludovic Jean
AU - Arnaud Blondel
AU - J. Iñaki Guijarro
AU - Denis Servent
AU - Rómulo Aráoz
PY - 2026
DA - 2026/05/22
JO - Chemosphere
DO - 10.1016/j.chemosphere.2026.144955
UR - https://cnrs.hal.science/hal-05798527v1
AB - Cyclic imine toxins are fast acting neurotoxins produced by dinoflagellates that are bioaccumulated by shellfish, which in turn, vectorize them to humans. Most cyclic imine toxins are potent antagonist of muscle and neuronal nicotinic acetylcholine receptors being able to cross the brain blood barrier. We report the discovery of ingrilimine, a novel cyclic imine toxin purified from Vulcanodinium rugosum (strain IFR-VRU-01). Its structure was determined by NMR, HRMS MS/MS and IR-spectroscopy. Ingrilimine bears a six-membered spirocyclic imine imbibed in a 13-carbon macrocycle (C24H35O2N; Mr 369.2663) and it is the smallest cyclic imine toxin described to date. Ingrilimine belongs to a novel emergent class of cyclic imines exhibiting potent cytotoxic and pro-apoptotic activities against human cancer cell lines. It also shows a high affinity for the human α7 nicotinic acetylcholine receptor displaying an intriguing dual activity: a concentration-dependent antagonist/agonist activity. Boltz-modeling of ingrilimine binding to human α7 nicotinic acetylcholine receptor rationalizes ingrilimine antagonist behavior, predicting at the same time the interaction of ingrilimine with the transmembrane domain of the receptor. Voltage clamp experiments using L247T and M253L receptor mutants indicate that Met253 located in transmembrane domain-2 may be essential for the ingrilimine-induced activation of α7 nicotinic acetylcholine receptor channel. Singular molecules like ingrilimine represent novel plausible routes for the treatment of neurodegenerative disorders and cancer where α7 nicotinic acetylcholine receptor plays a pivotal role. Harmful algal blooms are neglected sources of bioactive compounds with original scaffolds that can be used as drug leads for the treatment of human diseases.
SN - 0045-6535
SN - 1879-1298
ER -